Institutions / Gsk PLC
Gsk PLC
CIK 1131399 · Institution · as of Mar 31, 2026gsk.com ↗
Portfolio value
$599.15M
Positions
13
As of
Mar 31, 2026
Portfolio trend
Portfolio value
$599.15M-25.0%Positions
13-13.3%Top holdings
Mar 31, 2026
| Company | Value | % of portfolio |
|---|---|---|
| Crispr Therapeutics AG | $153.21M | 25.6% |
| Wave Life Sciences Ltd | $132.28M | 22.1% |
| BioNTech SEBNTX | $79.09M | 13.2% |
| Vir Biotechnology, Inc. | $76.62M | 12.8% |
| Ideaya Biosciences, Inc. | $44.43M | 7.4% |
| Lyell Immunopharma, Inc.LYEL | $30.34M | 5.1% |
| Cytokinetics Inc | $22.44M | 3.7% |
| Spero Therapeutics, Inc.SPRO | $21.51M | 3.6% |
| Fulcrum Therapeutics, Inc. | $13.70M | 2.3% |
| CVRx, Inc.CVRX | $9.53M | 1.6% |
| Bicycle Therapeutics plcBCYC | $7.10M | 1.2% |
| Nkarta, Inc.NKTX | $6.65M | 1.1% |
| REGENXBIO Inc. | $2.27M | 0.4% |
Activity
Mar 31, 2026View full history →
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Q1 2026 as of | Exit | SENS Senseonics Holdings, Inc. Common Stock | $-59.9K | -11K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Harvard Bioscience Inc Common stock | $-7.5K | -11K -100.00% | 0 | low |